High concentration of oxaliplatin may be a risk factor for vascular pain.

Satoru MatsunumaSatoko HandaHitomi YamamotoKiyoshi OkuyamaKoichi YoshimotoYasuhisa Kato

Published in: Journal of clinical pharmacy and therapeutics (2021)

High L-OHP concentration was identified as a significant risk factor for L-OHP-induced vascular pain. Our results indicate that the dilution of L-OHP may reduce the incidence of vascular pain.

Keyphrases

chronic pain
pain management
neuropathic pain
risk factors
high glucose
spinal cord
endothelial cells
high resolution
postoperative pain
simultaneous determination
tandem mass spectrometry